Back to search

Article

BRET-based self-cleaving biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery

2021-07-28

Abstract excerpt

The 3C-like protease (3CLpro) of SARS-CoV-2 is an attractive drug target for developing antivirals against SARS-CoV-2. A few small molecule inhibitors of 3CLpro are in clinical trials for COVID-19 treatments and more inhibitors are being developed. One limiting factor for 3CLpro inhibitors development is that the cellular activities of such inhibitors have to be evaluated in a Biosafety Level 3 (BSL-3) or BSL-4 la...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c7cebab-7c08-51f4-89e9-61a75c6e9a71
DOI
10.1101/2021.07.28.454072
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BRET-based self-cleaving biosensors for SARS-CoV-2 3CLpro Inhibitor DiscoveryDOI 10.1101/2021.07.28.454072
Select a neighboring publication to make it the new centre.